Evidence that interleukin-1 beta and tumor necrosis factor inhibit gastric fundus motility via the 5-lipoxygenase pathway

Eur J Pharmacol. 1994 Feb 11;252(3):253-60. doi: 10.1016/0014-2999(94)90170-8.

Abstract

In this study, we compared the effects of interleukin-1 beta and tumor necrosis factor (TNF) on in vitro rat gastric fundus motility. Interleukin-1 beta produced rapid, concentration-dependent relaxation of rat gastric fundus strips, similar to that seen with TNF, with a maximal effect at 30 U/ml and an estimated EC50 at 0.9 U/ml. The relaxant effects of interleukin-1 beta and TNF were not influenced by the inhibition of cyclooxygenase or nitric oxide-synthase activities. Interleukin-1 beta- and TNF-induced gastric relaxations were concentration dependently inhibited by BW 755c, which inhibits both cyclooxygenase and lipoxygenase, BW A4, which selectively inhibits the 5-lipoxygenase pathway, and SC 41930, a selective leukotriene B4 receptor antagonist, providing pharmacological evidence that leukotriene B4 is involved in the relaxant effects of both cytokines. The interleukin-1 beta- and TNF-induced activation of 5-lipoxygenase pathway did not appear to be triggered by phospholipase A2. An alternative pathway could involve the following steps: (i) activation of phospholipase C and the formation of diacylglycerol; (ii) diacylglycerol-induced activation of protein kinase C; (iii) formation of free arachidonic acid from diacylglycerol by diacylglycerol-lipase. This mechanism is suggested by the finding that leukotriene B4 is able to mimic cytokine-induced strip relaxation only in the presence of phorbol 12-myristate 13-acetate, which selectively activates protein kinase C.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Arachidonate 5-Lipoxygenase / metabolism*
  • Female
  • Gastric Fundus / drug effects*
  • Gastric Fundus / physiology
  • Gastrointestinal Motility / drug effects*
  • In Vitro Techniques
  • Interleukin-1 / pharmacology*
  • Leukotriene B4 / antagonists & inhibitors
  • Lipoxygenase Inhibitors / pharmacology
  • Male
  • Muscle Relaxation / drug effects
  • Muscle, Smooth / drug effects
  • Prostaglandins / metabolism
  • Rats
  • Rats, Wistar
  • Tetradecanoylphorbol Acetate / pharmacology
  • Tumor Necrosis Factor-alpha / pharmacology*

Substances

  • Interleukin-1
  • Lipoxygenase Inhibitors
  • Prostaglandins
  • Tumor Necrosis Factor-alpha
  • Leukotriene B4
  • Arachidonate 5-Lipoxygenase
  • Tetradecanoylphorbol Acetate